Rheumatology (Oxford). 2023 May 15:kead221. doi: 10.1093/rheumatology/kead221. Online ahead of print.
ABSTRACT
OBJECTIVE: To study whether multimodal brain magnetic resonance imaging (MRI) comprising permeability and perfusion measures coupled with machine learning could predict neurocognitive function in young patients with systemic lupus erythematosus (SLE) without neuropsychiatric manifestation.
METHODS: SLE patients and healthy controls (HCs) (age ≤ 40 years) underwent multimodal structural brain MRI that comprised voxel-based morphometry (VBM), magnetization transfer ratio (MTR) and dynamic contrast-enhanced (DCE) MRI in this cross-sectional study. Neurocognitive function assessed by Automated Neuropsychological Assessment Metrics was reported as the total throughput score (TTS). Olfactory function was assessed. A machine-learning based model (i.e. glmnet) was constructed to predict TTS.
RESULTS: Thirty SLE patients and 10 HCs were studied. Both groups had comparable VBM, MTR, olfactory bulb volume (OBV), olfactory function and TTS. While after correction for multiple comparisons the uncorrected increase in the blood-brain barrier (BBB) permeability parameters compared with HCs did not remain evident in SLE patients, DCE-MRI perfusion parameters, notably an increase in right amygdala perfusion, was positively correlated with TTS in SLE patients (r = 0.636, FDR p< 0.05). A machine-learning trained multimodal MRI model comprising alterations of VBM, MTR, OBV and DCE-MRI parameters mainly in the limbic system regions predicted TTS in SLE patients (r = 0.644, p< 0.0005).
CONCLUSION: Multimodal brain MRI demonstrated increased right amygdala perfusion that was associated with better neurocognitive performance in young SLE patients without statistically-significant BBB leakage and microstructural abnormalities. A machine learning-constructed multimodal model comprising microstructural, perfusion and permeability parameters accurately predicted neurocognitive performance in SLE patients.
PMID:37184855 | DOI:10.1093/rheumatology/kead221
